Drug shows promise for getting people to quit vaping– www.futurity.org

Go to Article
Excerpt from www.futurity.org

The first US trial of varenicline for e-cigarette cessation shows promising results and warrants larger-scale trials, researchers say.

The results of the study, published in the American Journal of Preventive Medicine, showed a significant disparity between the placebo group and the group receiving the medication.

“We had a 15% difference in quit rates, with those in the medication group having a quit rate of 45%,” says lead author Lisa Fucito, associate professor of psychiatry at Yale University School of Medicine and director of the Tobacco Treatment Service at the Yale Cancer Center and Smilow Cancer Hospital.

About The Author

pgnewser

See author's posts